Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Beginning Cash Balance: 2016-2024

Historic Beginning Cash Balance for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $103.8 million.

  • Organogenesis Holdings' Beginning Cash Balance fell 18.67% to $73.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.3 million, marking a year-over-year decrease of 4.01%. This contributed to the annual value of $103.8 million for FY2024, which is 0.94% up from last year.
  • Per Organogenesis Holdings' latest filing, its Beginning Cash Balance stood at $103.8 million for FY2024, which was up 0.94% from $102.8 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Beginning Cash Balance ranged from a high of $113.7 million in FY2022 and a low of $60.0 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Beginning Cash Balance had a median value of $103.8 million in 2024 and averaged $106.8 million.
  • Per our database at Business Quant, Organogenesis Holdings' Beginning Cash Balance skyrocketed by 253.88% in 2020 and then declined by 9.61% in 2023.
  • Organogenesis Holdings' Beginning Cash Balance (Yearly) stood at $60.0 million in 2020, then surged by 40.44% to $84.2 million in 2021, then spiked by 35.04% to $113.7 million in 2022, then dropped by 9.61% to $102.8 million in 2023, then grew by 0.94% to $103.8 million in 2024.